Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elmer Quintero

Psychiatry Decatur, GA Medical Doctor

NPI 1952628133 CMS profile 1298179

3073 Panthersville Rd Bldg 3, Decatur, GA 30034

Open in the dashboard

General payments

$154,861

321 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elmer Quintero of Decatur, GA is reported in the CMS Open Payments database as having received $154,861 across 321 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,756 30
2024 General $54,619 95
2023 General $14,983 46
2022 General $5,339 27
2021 General $2,894 15
2020 General $7,426 21
2019 General $55,843 87

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elmer Quintero
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Elmer Quintero were reported at $13,756. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Elmer Quintero Psychiatry median Middle half National median
2019 $55,843 $184 $59–$605 $163
2020 $7,426 $119 $36–$372 $114
2021 $2,894 $143 $43–$576 $132
2022 $5,339 $153 $50–$590 $149
2023 $14,983 $170 $56–$651 $160
2024 $54,619 $179 $57–$673 $164
2025 $13,756 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Otsuka America Pharmaceutical, Inc. $88,906 140 payments
  2. Janssen Pharmaceuticals, Inc $51,984 87 payments
  3. BioXcel Therapeutics, Inc. $10,524 26 payments
  4. E.R. Squibb & Sons, L.L.C. $1,764 7 payments
  5. Teva Pharmaceuticals USA, Inc. $515 10 payments
  6. Alkermes, Inc. $505 23 payments
  7. Indivior Inc. $267 11 payments
  8. Lundbeck LLC $193 9 payments
  9. Neurocrine Biosciences, Inc. $88 4 payments
  10. Otsuka Pharmaceutical Development & Commercialization, Inc. $66 1 payment
  11. Other $48 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $124,332 68 payments
  2. Travel and Lodging $21,710 70 payments
  3. Food and Beverage $7,438 182 payments
  4. Consulting Fee $1,380 1 payment
Products named General payments · program years 2019–2025
  1. ABILIFY MAINTENA $89,093 145 payments
  2. ABILIFY ASIMTUFII $60,621 74 payments
  3. SPRAVATO $34,095 45 payments
  4. INVEGA SUSTENNA $17,897 43 payments
  5. INVEGA TRINZA $17,060 29 payments
  6. IGALMI $10,524 26 payments
  7. UZEDY $515 10 payments
  8. ARISTADA Cns $505 23 payments
  9. ARISTADA Cns $505 23 payments
  10. LYBALVI $404 18 payments
  11. Other $2,034 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record